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ABSTRACT 
Objective: Development and validation of simple, stability indicating and green high performance liquid chromatographic (HPLC) method with 
ultraviolet (UV) detection for determination of cephalexin in pure form, pharmaceutical dosage forms and human urine samples.  
Methods: The method is based on using of a micellar mobile phase for separation of cephalexin and its degradation products. The analyte was 
chromatographed on a Kinetex C18
Results: Under optimized conditions the average recovery was ranged from 100.4–101.7%. The lower limit of quantification (LOQ) and the lower 
limit of detection (LOD) were 0.097 and 0.029 μg/ml, respectively. A linear correlation in the range of 1–200 μg/ml with the correlation coefficient 
(r
 75×4.6 mm, 2.6 μm column. Micellar mobile phase composed of 0.1M sodium dodecyl sulphate (SDS) and 10 % 
isopropanol (IPA), pH was adjusted to 3±0.05 with phosphoric acid, the flow-rate was 1.0 mL/min, the UV detector was set at 254 nm and the 
injection volume was 20 µl. Stability indicating properties of the proposed method was proved through exposure of the analyte solutions to 4 
different stress conditions of acidic, basic, oxidative and photo-irradiation conditions. 
2
Conclusion: The proposed method was found to be not only a greener method but also faster and more convenient than the USP compendial 
method. Greener here means that the method is more eco-friendly as it avoids usage of toxic solvent and reagent and switch to more benign 
chemicals. In addition, allow for injection of urine samples directly into an analytical column without pretreatment due to micellar solubilization of 
the interfering components of the biological samples.  
) of ≥ 0.999 was obtained. Relatively high inter-and intra-day precisions were achieved, the percentage RSD values were lower than 2. The 
obtained results were validated according to USP validation parameters. 




carboxylic acid monohydrate [1] (fig. 1), is a first-generation 
cephalosporin antibiotic it is a useful alternative to penicillin’s in 
patients with penicillin hypersensitivity. It is excreted in urine as 
unchanged drug by renal tubular secretion and glomerular filtration 
[2]. Many analytical methods have been reported for the analysis of 
cephalexin in pure drugs, dosage forms and biological fluids 
including its relevant monograph in USP [3].  
RP-HPLC methods for determination of cephalexin in plasma, serum 
and urine have been reported [4-6]. Other chromatographic, 
spectrophotometric and colorimetric methods have been developed 
for quantification of cephalexin [7-12]. At least 70–90% of a 
cephalexin dose is eliminated in urine within 8–12 hours in adults 
with normal renal function without change [13]. Micelle L. C has 
been introduced in several publications as more eco-friendly 
chromatographic technique in pharmaceutical testing [14-16]. 
The aim of this work is to develop and validate more eco-friendly 
(greener) stability indiating analytical methods, compared with the 
official one in USP without compromising efficacy, through 
minimizing usage of hazard organic solvents and switching to benign 
solvents in micellar liquid chromatography for determination of 
cephalexin in pharmaceutical dosage form and human urine as a 
biological samples.  
MATERIALS AND METHODS 
Materials and chemicals  
All materials were supplied by Sigma pharmaceuticals corp.-Egypt. 
Including cephalexin USP compendia reference standard "CRS" of 
100% purity, cephalexin pure material, commercial samples of 
starcef (cephalexin) 1g tablets and a placebo contains the same raw 
materials used in the production process including microcrystalline 
cellulose, povidone K 30, talc magnesium stearate, croscarmellose 
sodium and colloidal silicon dioxide, these materials are of 
pharmaceutical grade and are of the same type used for preparation 
of the drug product. All solvents and reagents are of HPLC grade. 
They were purchased from Sigma-Aldrish including sodium dodecyl 
sulphate (SDS), isopropanol IPA, and phosphoric acid. 
 
Fig. 1: Chemical structure of cephalexin 
 
Apparatus  
Shimadzu HPLC system (Shimadzu, Kyoto, Japan) equipped with 
SCL-10Avp system controller, LC-10ADvp pump, DGU-14A degasser, 
SIL-10ADvp auto sampler, CTO-10ACvp column oven, SPD-10Avp 
DAD detector, and Class-VP software was used to quantify the 
samples.  
Reference HPLC method 
According to the USP, the compendial HPLC method utilizing C18 
(250×4.6 mm, 5 μm) separation column and mobile phase composed 
of water, acetonitrile, methanol and triethylamine in the ratio (850: 
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100: 50: 15) and 0.0985 % of sodium 1-pentansulfonate. The pH is 
to be adjusted with phosphoric acid to 3±0.1. According to the green 
analytical chemistry parameters, this method would be greener if 
the time of analysis could be reduced and if it utilize more 
environmentally benign solvents and chemicals (or ideally eliminate 
the usage of organic solvent) without compromising the efficiency of 
the analytical procedure.  
Miceller liquid chromatography 
Preparation of stock solutions 
200 μg/ml stock standard solution of cephalexin was prepared in 
water, then calibrators were prepared by serial dilutions have been 
made using the mobile phase as solvent to prepare a series of the 
calibration standard solutions having concentration ranging from 1-
200 μg/ml. 
Tablets sample preparation 
Randomly selected 20 tablets were powdered and mixed; an 
accurately weighed portion of powder samples equivalent to 20 mg 
of cephalexin was dissolved and diluted to the appropriate volumes 
with water. Solutions were filtered through nylon sample filter 
(Whatman, 0.22μm). 
Urine sample preparation 
Blank human urine samples were collected freshly from health adult 
volunteers just before administration of starcef 1g tablets (zero 
time), other samples were collected at 6 and 8 hours intervals for 
quantitative determination of the drug.  
Urine samples were injected directly without dilution or extraction. 
They were only  
filtered through nylon sample filter (Whatman, 0.22μm). 
Stress degrdation of cephalexin under acidic, basic, oxidative 
and photo-irradiation conditions 
In order to determine the stability-indicating capacity and specificity 
of the proposed green HPLC method; forced degradation studies 
were performed at various stress conditions. Alkaline hydrolytic 
condition was applied by reflux a solution of 1 mg/ml of cephalexin 
solution with 0.1 N and 0.01 N sodium hydroxide solutions for 30 
minutes. For Acidic hydrolytic condition a solution of the same 
concentration was refluxed with 0.1 N hydrochloric acid solution. 
After reflux with acid or alkali solutions were cooled to room 
temperature, neutralized and diluted with water to the appropriate 
concentration. Reflux for one hour with 30 % hydrogen peroxide of a 
solution of 1 mg/ml cephalexin has been performed to achieve the 
oxidative hydrolysis condition, finally in photo-irradiation conditions 
cephalexin stock solution of 1 mg/ml was irradiated under a CAMAG 
200-W high-pressure mercury lamp for 10 hrs. The distance between 
the light source and the sample was maintained at 25 cm.  
Method development and chromatographic conditions 
The chromatographic conditions were selected on the basis of green 
analytical chemistry parameters. Micellar mobile phase composed of 
0.1M (SDS) and 10 % IPA, pH was adjusted to 3±0.05 with 
phosphoric acid, the flow-rate was 1.0 mL/min, the UV detector was 
set at 254 nm and the injection volume was 20 µl. The performance 
of two different separation columns was compared in terms of the 
system suitability parameters. Superficially porous particle (SPP) or 
"Core–Shell" packed column-Kinetex C18 75×4.6 mm, 2.6 μm and the 
conventional totally porous particle packed column (TPP)-Zorbax 
eclipse plus C18
RESULT AND DISCUSSION 
 100×4.6 mm, 5 μm.  
Optimization of the chromatographic conditions 
Considering green chemistry fundamentals [17], various solvent systems 
as mobile phases were compared for the development of a green and 
environmentally benign RP-HPLC method trough avoiding toxic solvent 
and reagents and use more benign ones. During the method 
development, different surfactants have been investigated at their 
critical micelle concentrations (CMC) such as Brij-L23, tween 80 and 
SDS; the initial separation time with all of them was too long (more than 
15 minutes) with inappropriate system suitability parameters as the 
peak shape was distorted with tailing factor more than 1.8.  
SDS (CMC = 8.27 mM) [18] was found to be the most appropriate 
surfactant for the separation. The SDS concentration has been 
increased gradually till 0.1 M to achieve the optimum 
chromatographic separation.  
Different organic modifiers such as ethanol and ethyl acetate were 
investigated but asymmetric peaks with unaccepted tailing factor 
and low number of theoretical plates were obtained. The most 
appropriate organic modifier was found to be IPA. 
The optimum mobile phase composition was found to be 0.1M SDS: 
IPA (90: 10) at pH 3 which gave excellent peak shape with 
asymmetry factor less than 1.3 and number of theoretical plates 
greater than 4000. The total run time was less than 10 min. as 
shown in fig.2 & fig. 3. The detection wavelength for the analysis of 
cephalexin was set at 254 nm as reported in USP [8]. 
Validation of the green RP-HPLC method  
The proposed green RP-HPLC method was validated according to 
the USP guidelines in terms of system suitability, linearity, limit of 
detection (LOD), limit of quantification (LOQ), accuracy, precision, 
robustness, specificity and selectivity. 
The system suitability was evaluated through repeated injections of 
cephalexin standard solution. The SPP short column offered 
excellent system suitability parameters including repeatable peak 
area, high column efficiency, low tailing factor, short and stable 
retention time and thus low consumption of the mobile phase which 
is in a good agreement with to the recommended green analytical 
chemistry parameters as shown in table 1. The linearity of the 
proposed method was evaluated by the linear least square analysis. 
Calibration curves were constructed form the series of dilutions of 
cephalexin standard solutions, in the range of 1–200 μg/ml for 
spiked drug matrix samples and urine samples. Calibrators were 
injected in triplicates and peak areas were plotted against 
concentrations. The equation for the calibration curves was 
calculated and the correlation coefficients were found to be 
R2
The accuracy was determined as percent recovery for spiked 
samples injected in triplicate of placebo solutions and urine samples 
at concentration levels ranged from 10–50 μg/ml. The percentage 
recoveries were ranged from (100.4–101.7%) with % RSD within 
2.0 % which indicated the accuracy of the proposed method as 
shown in table 3. 
>0.999 in all cases. The limits of detection LOD and limits of 
quantitation LOQ were considered as three and ten times of the 
noise level, respectively [19] as indicated in table 2. 
The precision of an analytical procedure expresses the closeness 
(degree of scatter) between a series of measurements obtained from 
multiple samplings of the same homogeneous sample under 
prescribed conditions; Inter-day precision was evaluated by 
analysing freshly prepared samples of drug-matrix and spiked urine 
sample in triplicates at three different concentration levels of 10, 30 
and 50 μg/ml. Intra-day precision was studied using freshly 
prepared similar solutions (n=6) at three different days. In all cases 
the RSD of the obtained results was lower than 2, these results are 
summarized in table 4. The ICH guidelines defined robustness of an 
analytical procedure as its capability to remain unaffected by small 
but deliberate variations in the method parameters [20-22]. 
Robustness was determined by monitoring the effect of slight 
changes in the separation conditions as illustrated in table 5. The 
percent recoveries of cephalexin were good under all studied 
conditions and did not show significant change (RSD = 0.47%) on 
slight change of the critical parameters. 
The specificity of the proposed green RP-HPLC method was proved 
by excellent chromatographic resolution of the target peak and 
different degradation product peaks under different forced 
degradation conditions where the resolution factor was greater than 
2 in all cases. The peak purity check indicated that the determined 
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purity factor was lower than the calculated threshold as shown in 
fig. 4. Cephalexine stock solution was exposed to various stress 
conditions. On treating cephalexin with 0.1 N NaOH complete 
degradation has been observed, when treated with 0.01 N NaOH for 
an hour, three degradation product peaks at 2.4, 3.7 and 4 minutes 
were observed with extensive degradation to 90 % of the peak of 
interest (fig. 5). Cephalexin was stable on treating with 0.1 N HCl but 
degrades to considerable extent on boiling in 0.1 N HCl for one hour, 
the height of peak was reduced by about 50 % and one new peak 
was observed at 2.5 minutes before peak of interest (fig. 6). 
Cephalexin was found to degrade more rapidly in oxidative 
conditions. Upon reflux with 30 % hydrogen peroxide for 30 
minutes, peak height was reduced dramatically with the appearance 
of new degradation peaks at 2.5 and 4.7 minutes (fig. 7). No 
significant changes in peak height under photo-irradiation 
conditions (Fig.8) which indicate photostability. 
 
 
Fig. 2: Cephalexin reference standard solution Under proposed green chromatographic conditions 
 
 
Fig. 3: Cephalexin test solution Under proposed green chromatographic conditions 
 
Table 1: System suitability parameters for comparison between the performance of SPP and TPP Columns (n=5) 
Parameter Kinetex C18 (75×4.6 mm, 2.6 μm)–SPP column Zorbax eclipse plus C18 (100×4.6 mm, 5 μm)-TPP column 
% RSD in retention time 0.048% 0.056% 
% RSD peak area 0.278% 0.315% 
tailing factor 1.25±0.05 1.55±0.05 
retention time±SD (min) 5.5±0.05  6.73±0.05  
HETP 56.6 67.17 
 
Table 2: Linearity of the calibration curve for cephalexin in standard preparations and in drug-matrix preparation. Number of points in 
the regression line is 3 for each case 
Variable Value (cephalexin in standard 
preparation) 
Value (cephalexin in drug-
matrix) 
Value (cephalexin in urine 
sample) 
Linearity range (µg/ml) 1–200 1–200 5–200 
Correlation coefficient (r2±SD) 0.999±0.0004 0.999±0.0005 0.999±0.005 
Slope 12619 12837.3 12167.5 
95% confidence interval for the 
slope 
11988.05-13249.95 12195.44-13479.16 11559.13-12775.87 
Intercept 7298 10075.42 51762.48 
95% confidence interval for the 
intercept 
6933.1-7662.9 9571.649-10579.19 49174.35-54350.6 
Regression equation y = 12619x+7298. y = 12837.3 x+10075.4 y = 12167.5 x±51762.5 
LOD (µg/ml) 0.029 0.06 0.11 
LOQ (µg/ml) 0.097 0.2 0.37 
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Table 3: Estimation of the accuracy in standard solution, drug matrix solution or urine sample (n=3) 













10 10.13±0.16 1.58 101.3 10.16±0.17 1.67 101.6 
30 30.24±0.43 1.42 100.8 30.50±0.51 1.67 101.7 
50 50.54±0.88 1.74 101.08 50.68±0.98 1.93 101.4 
 
Table 4: Precision data for the proposed HPLC method 
Time Tablet sample preparations Urine sample preparations 
Inter-day precision  
Sample concentration (µg/ml) 10 30 50 10 30 50 
Mean % recovery 99.76 100.38 99.18 101.12 99.62 100.34 
% RSD 0.05 0.11 0.09 0.29 0.18 0.23 
Intra-day precision 
Day-1 
Sample concentration (µg/ml) 10 30 50 10 30 50 
Mean % recovery 100.39 98.98 99.91 99.11 101.87 100.33 
% RSD 0.23 0.17 0.08 0.14 0.28 0.22 
Day-2 
Sample concentration (µg/ml) 10 30 50 10 30 50 
Mean % recovery 98.57 99.94 99.48 100.45 99.85 99.34 
% RSD 0.38 0.27 0.15 0.08 0.13 0.06 
Day-3 
Sample concentration (µg/ml) 10 30 50 10 30 50 
Mean % recovery 100.34 99.91 99.58 100.35 99.99 99.31 
% RSD 0.03 0.11 0.35 0.54 0.39 0.67 
 
Table 5: Effect of experimental parameters on the percent recoveries of cephalexin 
(%) recovery of cephalexin Modification Parameter 
 0.1M SDS: IPA Mobile phase 
100.1 93: 7 
99.35 90: 10 
101.1 87: 13 
100.5 SPP Type of column 
100.2 TPP 
100.1 3.1 pH 
100.3 3.0 
100.2 2.9 
100.1 0.9 Flow rate (ml/minute) 
99.95 1.0 
99.87 1.1 
100.1 260 Wavelength (nm) 
99.85 254 
99.90 245 
100.1 Nylon Filtration system 
100.7 PTFE 
99.4 Centrifuge 
100.1 25 °C Column temperature 
 100.3 27 °C 
0.47 % RSD (%) 
 
 
Fig. 4: Cephalexin peak purity by DDA detector, the purity factor was lower than the calculated threshold indicating the high selectivity of 
the proposed method 
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Fig. 5: Cephalexin solution under alkaline hydrolysis conditions 
 
 
Fig. 6: Cephalexin solution under acidic hydrolysis conditions 
 
 
Fig. 7: Cephalexin solution under oxidative hydrolysis conditions 
 
 
Fig. 8: Cephalexin solution under photo-degradation conditions 
 
Application of the proposed method 
The proposed method was found to be rapid, selective, sensitive and 
suitable for the quantitative determination of cephalexin in pure 
form, in finished drug form and in the urine sample. The last 
application (fig.9) is one of the major advantages of micellar 
chromatography due to the ability to directly inject physiological 
fluids because micelles have an ability to solubilize proteins, which 
enables MLC to be useful in analyzing untreated biological fluids 
such as plasma, serum, and urine [23]. 
 
 
Fig. 9: Cephalexin in urine sample injected as it is after 8 hours 
of oral administration 
 
CONCLUSION 
This study focus on micellar RP-HPLC tech which is considered 
greener than conventional HPLC technique as it utilize more eco-
friendly solvents and chemicals at the same time it is faster and 
could be used for analysis of biological fluids directly without 
compromising the efficiency. A valid and fast stability indicating 
HPLC method was developed. The proposed method ensures precise 
and accurate determination of cephalexin in tablet dosage form as 
well as human urine samples. No interference from the tablets 
excipients or interfering molecules in the urine samples. With the 
proposed method satisfactory separation of cephalexin from the 
degradation products was achieved and high recovery of the analyte 
was obtained.  
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